331
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants

, , , , &
Pages 2805-2813 | Accepted 11 Jul 2008, Published online: 27 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

E. Aguglia, R. Ravasio, M. Simonetti, S. Pecchioli & F. Mazzoleni. (2012) Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003–2009. Current Medical Research and Opinion 28:9, pages 1475-1484.
Read now
Larry Ereshefsky, Delphine Saragoussi, Nicolas Despiégel, Karina Hansen, Clément François & Khaled Maman. (2010) The 6-month persistence on SSRIs and associated economic burden. Journal of Medical Economics 13:3, pages 527-536.
Read now
Eric Q. Wu, Rym Ben-Hamadi, Andrew P. Yu, Jackson Tang, M. Haim Erder & Anjana Bose. (2010) Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons. Journal of Medical Economics 13:2, pages 314-323.
Read now
Nedim Havle, Yavuz Altunkaynak, Cengiz Dayan, M. Cem İlnem & Baki Arpacı. (2010) İnme Sonrası Depresyon Tedavisinde Essitalopram. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 20:1, pages 74-78.
Read now
Eric Q. Wu, Paul E. Greenberg, Elaine Yang, Andrew P. Yu, Rym Ben-Hamadi & M. Haim Erder. (2009) Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs. Journal of Medical Economics 12:2, pages 124-135.
Read now

Articles from other publishers (9)

Farrokh Alemi, Mai Aljuaid, Naren Durbha, Melanie Yousefi, Hua Min, Louisa G. Sylvia & Andrew A. Nierenberg. (2021) A surrogate measure for patient reported symptom remission in administrative data. BMC Psychiatry 21:1.
Crossref
Diana M. Sobieraj, Brandon K. Martinez, Adrian V. Hernandez, Craig I. Coleman, Joseph S. Ross, Karina M. Berg, David C. Steffens & William L. Baker. (2019) Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults. Journal of the American Geriatrics Society 67:8, pages 1571-1581.
Crossref
Elisabeth Kap, Marcel Konrad & Karel Kostev. (2019) Persistence with selective serotonin (norepinephrine) reuptake inhibitors in Germany—A retrospective database analysis. Journal of Affective Disorders 247, pages 156-160.
Crossref
Barbara Nussbaumer, Laura C. Morgan, Ursula Reichenpfader, Amy Greenblatt, Richard A. Hansen, Megan Van Noord, Linda Lux, Bradley N. Gaynes & Gerald Gartlehner. (2014) Comparative Efficacy and Risk of Harms of Immediate- versus Extended-Release Second-Generation Antidepressants: A Systematic Review with Network Meta-Analysis. CNS Drugs 28:8, pages 699-712.
Crossref
Chi-Shin Wu, Wen-Yi Shau, Hung-Yu Chan & Mei-Shu Lai. (2013) Persistence of antidepressant treatment for depressive disorder in Taiwan. General Hospital Psychiatry 35:3, pages 279-285.
Crossref
Yi-Ju Pan, Martin Knapp & Paul McCrone. (2012) Cost-effectiveness comparisons between antidepressant treatments in depression: Evidence from database analyses and prospective studies. Journal of Affective Disorders 139:2, pages 113-125.
Crossref
Faith M. Gunning & Gwenn S. Smith. (2011) Functional Neuroimaging in Geriatric Depression. Psychiatric Clinics of North America 34:2, pages 403-422.
Crossref
Gwenn S. Smith, Clifford I. Workman, Elisse Kramer, Carol R. Hermann, Rachel Ginsberg, Yilong Ma, Vijay Dhawan, Thomas Chaly & David Eidelberg. (2011) The Relationship Between the Acute Cerebral Metabolic Response to Citalopram and Chronic Citalopram Treatment Outcome. The American Journal of Geriatric Psychiatry 19:1, pages 53-63.
Crossref
. (2009) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 24:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.